PaxMedica, Inc.

OTCPK:PXMD Stock Report

Market Cap: US$11.0

PaxMedica Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Howard Weisman

Chief executive officer

US$1.1m

Total compensation

CEO salary percentage45.5%
CEO tenure4.9yrs
CEO ownership0.3%
Management average tenureno data
Board average tenure3.7yrs

Recent management updates

Recent updates

PaxMedica to debut on Nasdaq after pricing scaled-down $8.1M IPO

Aug 26

CEO Compensation Analysis

How has Howard Weisman's remuneration changed compared to PaxMedica's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-US$18m

Mar 31 2024n/an/a

-US$18m

Dec 31 2023US$1mUS$478k

-US$18m

Sep 30 2023n/an/a

-US$18m

Jun 30 2023n/an/a

-US$23m

Mar 31 2023n/an/a

-US$20m

Dec 31 2022US$4mUS$400k

-US$15m

Sep 30 2022n/an/a

-US$3m

Jun 30 2022n/an/a

US$4m

Mar 31 2022n/an/a

-US$2m

Dec 31 2021US$558kUS$400k

-US$10m

Compensation vs Market: Howard's total compensation ($USD1.05M) is above average for companies of similar size in the US market ($USD638.32K).

Compensation vs Earnings: Howard's compensation has been consistent with company performance over the past year.

CEO

Howard Weisman (65 yo)

4.9yrs

Tenure

US$1,050,224

Compensation

Mr. Howard J. Weisman has been the Chief Executive Officer and Director of PaxMedica Inc. since March 2020 and serves as its Chairman since August 21, 2023. Prior to joining PaxMedica, from September 2016...

Board Members

NamePositionTenureCompensationOwnership
Howard Weisman
CEO & Chairman4.9yrsUS$1.05m0.31%
$ 0.03
Charles Casamento
Lead Independent Director2.3yrsUS$98.83k0.0013%
$ 0.0001
Stefan K. Schwabe
Member of Scientific Advisory Board1.5yrsno datano data
Reymundo Lozano
Member of Advisory Boardno datano datano data
Karen LaRochelle
Independent Director4.6yrsUS$83.31k0.020%
$ 0.002
Michael Aman
Member of Scientific Advisory Boardno datano datano data
Zachary Rome
Director5.9yrsUS$358.28k0.091%
$ 0.01
Constance Smith-Hicks
Member of Scientific Advisory Boardno datano datano data
Alice Mao
Member of Scientific Advisory Boardno datano datano data
John Coelho
Independent Director2.8yrsUS$79.47k0.039%
$ 0.004
Veronica Martinez Cerdeno
Member of Advisory Boardno datano datano data
Robert Naviaux
Member of Scientific Advisory Boardno datano datano data

3.7yrs

Average Tenure

61yo

Average Age

Experienced Board: PXMD's board of directors are considered experienced (3.7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/11 08:55
End of Day Share Price 2025/02/11 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

PaxMedica, Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Boobalan PachaiyappanH.C. Wainwright & Co.